Present Status of Serum Tumor Markers in Diagnosis, Prognosis, and Evaluation of Therapy

This publication has 96 references indexed in Scilit:

• Values of CA 19-9 in the serum, pure pancreatic juice, and aspirated pancreatic material in the diagnosis of malignant pancreatic tumor
  Cancer, 1985
• Serum β2-microglobulin in patients with non-Hodgkin's lymphoma
  European Journal of Cancer and Clinical Oncology, 1983
• Age-related probability of development of hereditary medullary thyroid carcinoma
  The Journal of Pediatrics, 1982
• Brain-type creatine kinase BB as a potential tumour marker—Serum levels measured by radioimmunoassay in 1015 patients with histologically confirmed malignancies
  European Journal of Cancer and Clinical Oncology, 1982
• Serum beta-2-microglobulin in multiple myeloma: Relation to presenting features and clinical status
  European Journal of Cancer and Clinical Oncology, 1982
• Serum beta 2 microglobulin and C-reactive protein in the monitoring of lymphomas findings in a multicenter study and experience in selected patients
  Cancer, 1980
• Elevation of brain-type creatine kinase in serum from patients with carcinoma
  Cancer, 1979
• Serum β2 microglobulin and its prognostic value in lymphomas
  Published by Elsevier ,1979
• Total thyroidectomy for occult familial medullary carcinoma of the thyroid in children
  Journal of Pediatric Surgery, 1976
• Carcinoembryonic antigen (CEA): Demonstration of a partial identify between CEA and a normal glycoprotein
  Immunochemistry, 1972